Sr One Capital Management, LP Portfolio Holdings
Sr One Capital Management, LP
- $221 Million
- Q1 2025
Sr One Capital Management, LP has filed its 13F form on May 13, 2025 for Q1 2025 where it was disclosed a total value porftolio of $221 Million distributed in 12 stocks.
Among their holdings, we can observe that their the top five positions include companies like: Arcellx, Inc. with a value of $154M, Crispr Therapeutics Ag with a value of $35.7M, Design Therapeutics, Inc. with a value of $25.2M, Nkarta, Inc. with a value of $6.13M, and Alumis Inc. with a value of $0.
Examining the 13F form we can see an decrease of $47.6M in the current position value, from $269M to 221M.
Below you can find more details about Sr One Capital Management, LP portfolio as well as his latest detailed transactions.